To receive continuing education (CE) credit, you must complete the virtual lecture, CE posttest and activity evaluation.
1.25 CE contact hours for nurses and social workers
CE Credit Available Until: May 22, 2020
This activity has been designed to meet the educational needs of nurse practitioners, nurses, oncology social workers at intermediate and advanced levels involved in the care of patients with myeloma.
At the conclusion of this program, participants will be able to:
- List at least two new drugs/new applications to treat patients with myeloma along with monitoring and managing side effects
- Assess long-term and late effects of myeloma and myeloma treatments
- Identify populations at high-risk for myeloma
- Describe barriers patients face in accessing treatment and ways to address
Ann F. Mohrbacher, MD
Associate Professor of Clinical Medicine
Autologous Bone Marrow Transplant
Keck School of Medicine of the
University of Southern California
Los Angeles, CA
Katrice J. Royster, MS, RN, OCN
Senior Clinical Nurse II
University of Maryland
Marlene and Stewart Greenebaum
Comprehensive Cancer Center
Sponsors and Supporters
This activity is supported by The Leukemia & Lymphoma Society.